Symbol="HILS"
AssetType="Common Stock"
Name="Hillstream Biopharma Inc"
Description="Hillstream BioPharma, Inc., a preclinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anticancer mechanism that causes iron-mediated cell death (IMCD) for refractory cancers. The company is headquartered in Bridgewater, New Jersey."
CIK="1861657"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1200 ROUTE 22 EAST, BRIDGEWATER, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="6053100"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="0.278"
DividendPerShare="0"
DividendYield="0"
EPS="-0.67"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.641"
ReturnOnEquityTTM="-1.214"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.67"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.883"
EVToRevenue="-"
EVToEBITDA="-3.513"
Beta="None"
num_52WeekHigh="2.059"
num_52WeekLow="0.303"
num_50DayMovingAverage="0.386"
num_200DayMovingAverage="0.668"
SharesOutstanding="16814100"
DividendDate="None"
ExDividendDate="None"
symbol="HILS"
open="0.35"
high="0.36"
low="0.35"
price="0.36"
volume="71448.00"
latest_trading_day="2023-07-11"
previous_close="0.35"
change="0.01"
change_percent="2.2147%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="51"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="49"
Volume_recent_avg="509803"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-1.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="49"
Aroon_momentum_negative="51"
image_negative_thumbnail_id_1="1117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_negative_thumbnail_id_2="156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0020.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="640"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0068.jpeg"
image_positive_thumbnail_id_2="656"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
